Cabaletta Bio (CABA)
US Market

Cabaletta Bio (CABA) Financial Statements


Cabaletta Bio Financial Overview

Cabaletta Bio's market cap is currently ―. The company's EPS TTM is $-1.722; its P/E ratio is -4.85; Cabaletta Bio is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -28.03M$ -23.15M$ -16.45M$ -14.49M$ -15.85M
EBITDA$ -27.64M$ -22.81M$ -16.75M$ -14.29M$ -15.50M
Net Income Common Stockholders$ -25.05M$ -23.08M$ -16.45M$ -14.49M$ -15.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 223.84M$ 241.25M$ 164.39M$ 176.33M$ 93.84M
Total Assets$ 240.46M$ 253.65M$ 173.29M$ 184.64M$ 103.45M
Total Debt$ 8.17M$ 5.02M$ 4.27M$ 4.20M$ 4.67M
Net Debt$ -215.68M$ -236.23M$ -160.12M$ -172.13M$ -89.17M
Total Liabilities$ 18.74M$ 17.45M$ 12.36M$ 10.50M$ 11.80M
Stockholders Equity$ 221.72M$ 236.20M$ 160.92M$ 174.14M$ 91.65M
Cash Flow-
Free Cash Flow$ -24.80M$ -16.63M$ -12.67M$ -11.95M$ -12.99M
Operating Cash Flow$ -23.99M$ -16.45M$ -12.60M$ -11.89M$ -12.61M
Investing Cash Flow$ -812.00K$ 1.14M$ -65.00K$ -48.14M$ 24.62M
Financing Cash Flow$ 6.86M$ 93.05M$ 98.00K$ 94.26M$ 226.00K
Currency in USD

Cabaletta Bio Earnings and Revenue History

Cabaletta Bio Debt to Assets

Cabaletta Bio Cash Flow

Cabaletta Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis